Albendazole for Loa loa worm infection
Treatments studied
Part of Infections, Skin clinical trials.
This trial is testing the drug albendazole in people who have Loa loa, a worm infection that can cause itchy swellings. The study will see if a 21-day course of albendazole helps clear the infection better than a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old
- You must weigh between 40 and 90 kg (about 88 to 198 pounds)
- You must have been diagnosed with Loa loa (a worm infection spread by deer fly bites)
- You cannot have serious liver, kidney, or bone marrow problems
- You cannot have epilepsy or other neurological conditions
- You cannot be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how safe and effective a combined albendazole and ivermectin pill is for treating parasitic infections. It is for school-aged children in specific areas of Ghana and Kenya.
This study compares two different medicine combinations given to entire communities to treat and prevent lymphatic filariasis (a parasitic infection that causes swelling). The goal is to find a better way to deliver these medicines to reduce the disease in affected areas.
This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.
This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.
This study tests if higher doses of arpraziquantel can safely treat children infected with the liver fluke Opisthorchis viverrini. It aims to find the best dose that clears the infection.
This study tests a new pill called lotilaner for safety and how well it works to kill mosquitoes that carry malaria. It is for healthy adults in Mali and may help future malaria prevention efforts.
Hear when a new Loiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.